Tushar Manudhane
Stock Analyst at Motilal Oswal
(3.51)
# 2,295
Out of 5,152 analysts
17
Total ratings
100%
Success rate
46.1%
Average return
Main Sectors:
Stocks Rated by Tushar Manudhane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Hold | ₹5,770 → ₹5,890 | ₹5,223 | +12.78% | 3 | Nov 12, 2026 | |
| NSE: CIPLA Cipla Limited | Reiterated: Hold | ₹1,420 → ₹1,450 | ₹1,417 | +2.33% | 3 | Oct 27, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Reiterated: Buy | ₹2,300 → ₹2,330 | ₹2,330 | - | 2 | Oct 21, 2026 | |
| NSE: ASTERDM Aster DM Quality Care Limited | Initiated Coverage: Buy | ₹910.00 | ₹733.00 | +24.15% | 1 | Sep 1, 2026 | |
| NSE: RUBICON Rubicon Research Limited | Reiterated: Buy | ₹1,160 → ₹1,915 | ₹1,658 | +15.48% | 3 | Aug 15, 2026 | |
| NSE: GLAND Gland Pharma Limited | Reiterated: Buy | ₹3,080 | ₹3,227 | -4.56% | 1 | Aug 10, 2026 | |
| NSE: MEDANTA Global Health Limited | Reiterated: Buy | ₹1,670 | ₹1,440 | +15.97% | 1 | Aug 1, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹2,640 | ₹2,625 | +0.57% | 1 | Apr 29, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹8,050 | ₹8,821 | n/a | 1 | May 31, 2025 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Reiterated: Buy | ₹1,370 | ₹1,796 | n/a | 1 | May 28, 2025 |
Alkem Laboratories Limited
Nov 12, 2026
Reiterated: Hold
Price Target: ₹5,770 → ₹5,890
Current: ₹5,223
Upside: +12.78%
Cipla Limited
Oct 27, 2026
Reiterated: Hold
Price Target: ₹1,420 → ₹1,450
Current: ₹1,417
Upside: +2.33%
Emcure Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: ₹2,300 → ₹2,330
Current: ₹2,330
Upside: -
Aster DM Quality Care Limited
Sep 1, 2026
Initiated Coverage: Buy
Price Target: ₹910.00
Current: ₹733.00
Upside: +24.15%
Rubicon Research Limited
Aug 15, 2026
Reiterated: Buy
Price Target: ₹1,160 → ₹1,915
Current: ₹1,658
Upside: +15.48%
Gland Pharma Limited
Aug 10, 2026
Reiterated: Buy
Price Target: ₹3,080
Current: ₹3,227
Upside: -4.56%
Global Health Limited
Aug 1, 2026
Reiterated: Buy
Price Target: ₹1,670
Current: ₹1,440
Upside: +15.97%
Mankind Pharma Limited
Apr 29, 2026
Reiterated: Buy
Price Target: ₹2,640
Current: ₹2,625
Upside: +0.57%
Apollo Hospitals Enterprise Limited
May 31, 2025
Reiterated: Buy
Price Target: ₹8,050
Current: ₹8,821
Upside: n/a
Aurobindo Pharma Limited
May 28, 2025
Reiterated: Buy
Price Target: ₹1,370
Current: ₹1,796
Upside: n/a